The outcome of BRAF mutated cases in a large cohort of PTC is presented and discussed
Low-Risk Differentiated Thyroid Cancer with BRAFV600E mutation is more difficult to cure than negative cases: a 5-year follow-up study.
VIOLA, DAVID;GIANNINI, RICCARDO;Ugolini, C.;BIAGINI, AGNESE;MOLINARO, ELEONORA;AGATE, LAURA;BASOLO, FULVIO;PINCHERA, ALDO;ELISEI, ROSSELLA
2011-01-01
Abstract
The outcome of BRAF mutated cases in a large cohort of PTC is presented and discussedFile in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
